Treatment of leprosy in the United States.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007167:Immunotherapy; D007917:Leprostatic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007918:Leprosy / Q000188:drug therapy* / Q000517:prevention & control / Q000628:therapy; D008297:Male; D013792:Thalidomide / Q000627:therapeutic use; D014481:United States
D000305:Adrenal Cortex Hormones; D007917:Leprostatic Agents; D013792:Thalidomide